Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection
Journal of Microbiological Methods · 2024-07 · 222 · 106944
DOI: 10.1016/j.mimet.2024.106944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiological Methods, 2024-07. Verfasst von Xiangyu Xi und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Latent Tuberculosis, Exosomes, Biomarkers, Tuberculosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Xuzhou Science and Technology Bureau.
Abstract (Originalsprache)
OBJECTIVE: To analyse the expression profiles of serum exosome tRFs/tiRNAs and to explore their diagnostic value in tuberculosis (TB) activity. METHODS: The serum exosome tRF/tiRNA profile was analysed using high-throughput sequencing technology in 5 active tuberculosis (ATB) patients, 5 latent tuberculosis infection (LTBI) patients and 5 healthy controls (HCs). Then, serum exosome tRFs/tiRNAs were validated by quantitative real-time polymerase chain reaction (qRT-PCR), and their diagnostic value was evaluated by receiver operating characteristic curve (ROC) and area under the curve (AUC). Finally, bioinformatics analysis was performed to explore and identify the potential biological pathways induced by tRFs/tiRNAs. RESULTS: The sequencing results revealed that serum exosome tRF/tiRNA expression profiles were different among ATB patients, LTBI patients and HCs. Three tRFs (tRF-56:75-Trp-CCA-4, tRF-1:22-chrM.Ser-GCT and tRF-56:76-Val-TAC-1-M2) were selected for qRT-PCR validation. The results demonstrated that the expression level of tRF-1-22-chrM.Ser-GCT was upregulated in ATB patients, while tRF-56-75-Trp-CCA-4 was downregulated, which was consistent with the sequencing data. The AUCs of tRF-56:75-Trp-CCA-4 and tRF-1:22-chrM. Ser-GCT were 0.824 and 1.000, respectively, which have significant values in the diagnosis of ATB patients. Moreover, the expression levels of tRF-56:75-Trp-CCA-4 and tRF-1:22-chrM.Ser-GCT and tRF-56:76-Val-TAC-1-M2 in ATB patients and LTBI were different, which indicated that these three tRFs could effectively distinguish ATB patients and LTBI patients. CONCLUSION: Our findings indicate that serum exosome tRFs can be used as potential markers for the diagnosis of ATB and LTBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu, China.
- Department of Epidemiology, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Xuzhou Infectious Disease Hospital, Xuzhou, Jiangsu, China.
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Electronic address: linchunhua88@hotmail.com.
Förderung
- Xuzhou Science and Technology Bureau
Zitieren
APA
Xi, X., Wang, B., Zhang, R., & Ling, C. (2024). Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection. Journal of Microbiological Methods, 222, 106944. https://doi.org/10.1016/j.mimet.2024.106944
Vancouver
Xi X, Wang B, Zhang R, Ling C. Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection. Journal of Microbiological Methods. 2024;222:106944. doi:10.1016/j.mimet.2024.106944
BibTeX
@article{Xi2024,
author = {Xi, Xiangyu and Wang, Binghua and Zhang, Ruimei and Ling, Chunhua},
title = {Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection},
journal = {Journal of Microbiological Methods},
year = {2024},
volume = {222},
pages = {106944},
doi = {10.1016/j.mimet.2024.106944}
}
EUVIMED